Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 4/20 | 0.67 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | MAOA | P21397 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | PKLR | P30613 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29407198 | 1.00 | BCL2 (0.67) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL3955176 | 0.87 | BCL2 (0.67) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL28019688 | 0.82 | MAPT (0.55) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL23198952 | 0.81 | MAPT (0.61) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL555230 | 0.80 | BCL2 (1.00) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL29384381 | 0.80 | BCL2 (1.00) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL29388375 | 0.80 | BCL2 (1.00) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL23199041 | 0.80 | MAPT (0.60) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL5075855 | 0.79 | ALDH1A1 (0.52) | BCL2MCL1ALDH1A1MEN1MAPT | |
| SCHEMBL29360530 | 0.79 | ALDH1A1 (0.52) | BCL2MCL1ALDH1A1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | claimed |
| EP-1381355-A2 | MATRIX METALLOPROTEINASE INHIBITORS | KIMBERLY-CLARK CORPORATION (US) | 2004-01-21 | — | — | EP | claimed |
| US-6600057-B2 | Derivatives of 4,5-dihydroxyanthraquinone-2-carboxylic acid; wound healing agents | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-29 | — | — | US | claimed |
| WO-2002053146-A2 | MATRIX METALLOPROTEINASE INHIBITORS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2002-07-11 | — | — | WO | claimed |
| US-20020086877-A1 | Matrix metalloproteinase inhibitors | AVENT, INC. | 2002-07-04 | — | — | US | claimed |
| US-4602913-A | Use of hydroxyanthraquinones for the coloration of human keratin fibres | L'OREAL (FR) | 1986-07-29 | — | — | US | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | disclosed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | disclosed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | disclosed |
| EP-0665775-B1 | ANTHRAQUINONE INHIBITION OF METHANE PRODUCTION IN METHANOGENIC BACTERIA | BIO TECH RESOURCES (US) | 1997-09-03 | — | — | EP | disclosed |
| US-5648258-A | CONTROLLING METHANE PRODUCTION FOR BETTER FEED EFFICIENCY IN CATTLE | BIO-TECHNICAL RESOURCES (US) | 1997-07-15 | — | — | US | disclosed |
| EP-0665775-A1 | ANTHRAQUINONE INHIBITION OF METHANE PRODUCTION IN METHANOGENIC BACTERIA. | BIO TECH RESOURCES (US) | 1995-08-09 | — | — | EP | disclosed |
| WO-1994008738-A1 | ANTHRAQUINONE INHIBITION OF METHANE PRODUCTION IN METHANOGENIC BACTERIA | BIO-TECHNICAL RESOURCES LP (US) | 1994-04-28 | — | — | WO | disclosed |
| EP-0234084-A1 | Rubber composition, an article of rubber reinforced with brass plated steel and a method of making such an article | GENCORP INC. (US) | 1987-09-02 | — | — | EP | disclosed |
| US-4615369-A | POLYHYOROXY ANTHRAQUINONE FOR IMPROVED HUMID AGED ADHESION; TIRES | GENCORP (US) | 1986-10-07 | — | — | US | disclosed |
| US-4602913-A | Use of hydroxyanthraquinones for the coloration of human keratin fibres | L'OREAL (FR) | 1986-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086877-A1 | Matrix metalloproteinase inhibitors | MMP26, MMP13, MMP9 | BCL2 1225/4885MCL1 1447/4885ALDH1A1 283/4885 |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | BCL2 2450/4885MCL1 2381/4885ALDH1A1 3685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.